Evidence map›Paper›PMID 41922985›Full record

ArticleBMC infectious diseases2026

Rare concurrent invasive pulmonary aspergillosis in a critically Ill patient with hemorrhagic fever with renal syndrome: a case report.

Weiwei Yan, Alin Sun, Liming Wang, Jihong Zhang, Peng Chen

Abstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Weiwei YanDepartment of Critical Care Medicine, Weifang People's Hospital, Weifang, Shandong Province, China.
Alin SunDepartment of Critical Care Medicine, Weifang People's Hospital, Weifang, Shandong Province, China.
Liming WangDepartment of Critical Care Medicine, Weifang People's Hospital, Weifang, Shandong Province, China.
Jihong ZhangDepartment of Critical Care Medicine, Weifang People's Hospital, Weifang, Shandong Province, China.
Peng ChenCardiac Critical Care and Rehabilitation Department, Weifang People's Hospital, Weifang, Shandong Province, China. 953695010@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHantavirus infection frequently results in hemorrhagic fever with renal syndrome, which may be fatal in certain instances. invasive pulmonary aspergillosis is a rare concurrent symptom that requires considerable attention from clinicians. CASE PRESENTATION: This report describes a case of a male patient, age 55, who had periorbital pain, fever, and oliguria but no risk indicators for invasive pulmonary aspergillosis. He was admitted to the intensive care unit due to respiratory failure, oliguria, and shock. The diagnosis of hemorrhagic fever with renal syndrome complicated by invasive pulmonary aspergillosis was confirmed by bronchoscopy and chest CT. After 45 days in the hospital, the patient recovered completely after receiving 27 days of treatment in the intensive care unit.

conclusionsHemorrhagic fever with renal syndrome(HFRS) complicated by invasive pulmonary aspergillosis is infrequently observed in clinical practice. Consequently, in patients with HFRS exhibiting pulmonary injury, the prompt identification of interstitial pneumonia is essential.

Indexed as

Hemorrhagic Fever with Renal SyndromeInvasive Pulmonary AspergillosisAntifungal AgentsCritical IllnessHumansIntensive Care UnitsMaleMiddle AgedTomography, X-Ray ComputedAntifungal AgentsHantavirusHemorrhagic fever with renal syndromeInfectionInvasive pulmonary aspergillosis

Identifiers

PMID41922985
PMCPMC13169553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.